In October of last year, The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) conducted a survey with Dermik Laboratories and found that more than half of women considering facial plastic surgery say that the economy has affected their choices in cosmetic treatments. Over 30% of these women have looked for injectables or other non-surgical alternatives - which carry a lower price tag.
Some fillers offer a fast, yet temporary improvement for months, or as much as a year, and only around 8% of those surveyed said this was preferred. A full 92% preferred an injectable treatment like Sculptra that provides gradual results and last a full two years. These women wanted a product that treats wrinkles, lines and folds. A gradual improvement is less likely to be noticed by friends and co-workers, so patients can keep their cosmetic work secret.
Sculptra was originally developed to combat the appearance of hollowed cheeks which result from treatment for AIDS patients, and was found to be effective as an aesthetic treatment as well. In 2009, ScultpraAesthetic was approved by the FDA to treat deep smile lines, contour deficiencies and other facial wrinkles and can last up to 2 years, the only drug that currently offers such a lasting result. Most patients undergo only 3 injection sessions over the course of a few months to acheive their final results.
Though many patients do prefer a gradual result, there are some who seek out a quick fix for an upcoming event and don't want to wait. For these women, there are some treatments available that offer lasting - and quick - results. Fractional resurfacing patients typically see reduction of their redness by 2 weeks, and with care, can see long term results from laser devices such as Fraxel. Radiofrequency (RF) devices like the Reaction by Viora and Thermage don't resurface the skin, but do tighten it by stimulating collagen growth. They have a short downtime as well, and the improvements continue over time and have the potential to last for years.